Highlighting Women With Bleeding Disorders at the European DIU Programme – EHC
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“The EHC is in Lyon this week to share our expertise with the European Inter-University Certificate in Clinical Haemostasis (DIU Européen d’Hémostase Clinique), hosted at Hôpital Louis Pradel in Bron and led by Prof Yesim Dargaud.
This intensive programme brings together physicians from across the French-speaking European community to train in bleeding and thrombotic disorders.
We are proud to contribute the bleeding disorders patient perspective throughout the week, presenting ‘Women Bleed Too‘ — shining a light on the fact that bleeding disorders affect women too, and that their experiences must shape how we train and treat.
Highlights this week include clinical case presentations by high-level experts Dr Maria Elisa Mancuso and Dr Cedric Hermans, exploring best practices and treatment options in haemostasis care.
Patient advocacy and medical education: stronger together.”
Other posts featuring EHC on Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’